Cervinka J, Kaláb M, Jedlicka J, Petrtýl J, Marecek Z
I. interní klinika 1. lékarské fakulty Univerzity Karlovy, Praha.
Cas Lek Cesk. 1991 Feb 22;130(8):231-2.
The authors assessed in 12 patients with compensated cirrhosis of the liver, portal hypertension and oesophageal varices, using a Doppler flowmeter Toshiba SAL 50A/SDL 01 under basal conditions, changes in the width, rate of blood flow and blood flow though the trunk of the portal vein before and after intravenous administration of 1 mg glucagon. The width of the trunk of the portal vein did not change significantly during assessment. A statistically significantly increased flow through the portal vein was recorded starting during the 5th minute, and it correlated with the increased velocity of the blood flow. The increased flow persisted to the 20th minute after glucagon administration. The drop of pressure in a wedged position assessed in the hepatic veins after administration of the drug was not significant, the pressure in the free hepatic vein increased insignificantly. On the whole the portohepatic gradient declined by 10.5%, the drop was not significant. Glucagon in pharmacological doses has an early onset of action even in cirrhotic subjects whereby the increased flow through the portal vein does not lead to a rise of the portohepatic gradient. Glucagon administration thus does not increase the risk of haemorrhage from oesophageal varices during acute fibroscopy of the oesophagus and stomach in patients with portal hypertension.
作者对12例代偿期肝硬化、门静脉高压和食管静脉曲张患者,在基础状态下使用东芝SAL 50A/SDL 01型多普勒流量计,评估静脉注射1毫克胰高血糖素前后门静脉主干的宽度、血流速度和血流量的变化。评估过程中门静脉主干宽度无明显变化。从第5分钟开始记录到门静脉血流显著增加,且与血流速度增加相关。胰高血糖素给药后,血流增加持续到第20分钟。给药后肝静脉楔压下降不显著,肝静脉自由压略有升高。总体而言,门静脉肝静脉压差下降了10.5%,下降不显著。药理剂量的胰高血糖素即使在肝硬化患者中也有早期起效作用,门静脉血流增加并不会导致门静脉肝静脉压差升高。因此,在门静脉高压患者进行食管和胃急性纤维内镜检查时,注射胰高血糖素不会增加食管静脉曲张出血的风险。